Clinical Safety and Efficacy Evaluation of NanoLithium® NP03 in Patients With Mild-to-severe Alzheimer's Disease
Clinical trial NCT05423522 · COMPLETED
Trial details
- NCT number
- NCT05423522
- Sponsor
- Medesis Pharma SA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-20
- Primary completion
- 2024-01-23
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.